# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CounterPath (NASDAQ:CPAH) reported quarterly earnings of $0.04 per share. This is a 133.33 percent increase over losses of $(0....
Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares climbed 115% to close at $2.30 on Monday after declining around 5% o...
Gainers Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares jumped 115.9% to $2.31 after declining around 5% on Friday.
CounterPath Corporation (NASDAQ:CPAH)(TSX:PATH) ("CounterPath" or the "Company"), a global provider of award-wi...